Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 7 | 2022 | 203 | 2.850 |
Why?
|
| Cholestasis, Intrahepatic | 3 | 2022 | 74 | 1.720 |
Why?
|
| Biliary Atresia | 8 | 2018 | 191 | 1.630 |
Why?
|
| Rotavirus Infections | 5 | 2013 | 287 | 1.200 |
Why?
|
| Bilirubin | 6 | 2021 | 221 | 0.720 |
Why?
|
| Premature Birth | 1 | 2021 | 407 | 0.570 |
Why?
|
| Rotavirus Vaccines | 2 | 2013 | 67 | 0.530 |
Why?
|
| Alagille Syndrome | 3 | 2022 | 44 | 0.470 |
Why?
|
| Immunization, Passive | 1 | 2013 | 172 | 0.440 |
Why?
|
| Rotavirus | 2 | 2012 | 377 | 0.410 |
Why?
|
| Bile Ducts | 1 | 2012 | 113 | 0.400 |
Why?
|
| Osteopontin | 1 | 2011 | 148 | 0.380 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2022 | 299 | 0.370 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 30 | 0.290 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2022 | 421 | 0.280 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 93 | 0.270 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 333 | 0.270 |
Why?
|
| Liver Diseases | 2 | 2022 | 574 | 0.260 |
Why?
|
| Up-Regulation | 1 | 2011 | 2450 | 0.250 |
Why?
|
| Liver | 5 | 2022 | 2961 | 0.250 |
Why?
|
| Infant | 14 | 2021 | 13310 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2018 | 544 | 0.220 |
Why?
|
| Nutrition Assessment | 1 | 2023 | 169 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1945 | 0.210 |
Why?
|
| Child, Preschool | 9 | 2021 | 16273 | 0.210 |
Why?
|
| Blood Glucose | 1 | 2006 | 1244 | 0.210 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2011 | 107 | 0.190 |
Why?
|
| Failure to Thrive | 2 | 2018 | 91 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 171 | 0.180 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2015 | 40 | 0.160 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 1178 | 0.160 |
Why?
|
| Child | 9 | 2023 | 29154 | 0.160 |
Why?
|
| Portoenterostomy, Hepatic | 2 | 2018 | 48 | 0.160 |
Why?
|
| Animals, Newborn | 2 | 2013 | 1338 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 158 | 0.160 |
Why?
|
| Etodolac | 1 | 2017 | 3 | 0.160 |
Why?
|
| Gestational Age | 1 | 2021 | 1069 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 2314 | 0.150 |
Why?
|
| Enterohepatic Circulation | 1 | 2017 | 11 | 0.150 |
Why?
|
| Hyperbilirubinemia | 1 | 2017 | 78 | 0.150 |
Why?
|
| Growth Disorders | 1 | 2018 | 218 | 0.150 |
Why?
|
| Liver Cirrhosis | 4 | 2022 | 941 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2018 | 110 | 0.150 |
Why?
|
| Thinking | 1 | 2017 | 33 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 354 | 0.150 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2017 | 200 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2021 | 8223 | 0.140 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.140 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2015 | 8 | 0.140 |
Why?
|
| Bone Density | 1 | 2018 | 476 | 0.130 |
Why?
|
| Male | 22 | 2023 | 123000 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 97 | 0.130 |
Why?
|
| Avitaminosis | 1 | 2014 | 4 | 0.130 |
Why?
|
| Pregnancy | 2 | 2021 | 7573 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2016 | 165 | 0.130 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 275 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2021 | 12873 | 0.120 |
Why?
|
| Female | 21 | 2023 | 141928 | 0.120 |
Why?
|
| Hypertension, Portal | 1 | 2015 | 124 | 0.120 |
Why?
|
| Cognition | 2 | 2018 | 968 | 0.120 |
Why?
|
| Prednisolone | 1 | 2014 | 123 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 2014 | 193 | 0.120 |
Why?
|
| Memory | 1 | 2017 | 429 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 674 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 246 | 0.110 |
Why?
|
| Bias | 1 | 2013 | 205 | 0.110 |
Why?
|
| Hypertension | 1 | 2022 | 1503 | 0.110 |
Why?
|
| Double-Blind Method | 4 | 2022 | 2588 | 0.100 |
Why?
|
| Health Status | 1 | 2015 | 590 | 0.100 |
Why?
|
| Rodent Diseases | 1 | 2011 | 29 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 441 | 0.100 |
Why?
|
| Viremia | 1 | 2011 | 177 | 0.090 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2009 | 34 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 7222 | 0.090 |
Why?
|
| Lipids | 2 | 2023 | 644 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2013 | 786 | 0.080 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2006 | 51 | 0.070 |
Why?
|
| Global Health | 1 | 2012 | 657 | 0.070 |
Why?
|
| Body Weight | 2 | 2023 | 1293 | 0.070 |
Why?
|
| Capillaries | 1 | 2006 | 99 | 0.070 |
Why?
|
| Sugars | 1 | 2023 | 15 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 787 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 4113 | 0.060 |
Why?
|
| Depression | 1 | 2013 | 1715 | 0.060 |
Why?
|
| Biomarkers | 3 | 2022 | 5047 | 0.060 |
Why?
|
| Endoglin | 1 | 2022 | 43 | 0.060 |
Why?
|
| Animals | 3 | 2013 | 59536 | 0.060 |
Why?
|
| Adolescent | 6 | 2022 | 31252 | 0.060 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 32 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2027 | 0.050 |
Why?
|
| Thrombosis | 1 | 2009 | 781 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 1546 | 0.050 |
Why?
|
| Losartan | 1 | 2022 | 46 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2017 | 901 | 0.050 |
Why?
|
| Incidence | 1 | 2012 | 5673 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2011 | 5710 | 0.050 |
Why?
|
| Mutation | 1 | 2021 | 15179 | 0.050 |
Why?
|
| Biopsy | 2 | 2022 | 3443 | 0.050 |
Why?
|
| Mice | 2 | 2013 | 34495 | 0.050 |
Why?
|
| Quality of Life | 1 | 2015 | 4532 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2022 | 9244 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 151 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 519 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2020 | 115 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2018 | 1819 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2022 | 32848 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 4298 | 0.040 |
Why?
|
| Cephalometry | 1 | 2018 | 39 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 793 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4557 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 239 | 0.040 |
Why?
|
| Catheterization | 1 | 2020 | 410 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 140 | 0.040 |
Why?
|
| Motor Skills | 1 | 2018 | 107 | 0.040 |
Why?
|
| Risk Factors | 2 | 2012 | 17523 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2017 | 355 | 0.040 |
Why?
|
| Adult | 5 | 2022 | 77950 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 1099 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 167 | 0.030 |
Why?
|
| Child Development | 1 | 2018 | 255 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 6009 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 1467 | 0.030 |
Why?
|
| Jaundice | 1 | 2015 | 39 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 502 | 0.030 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 9 | 0.030 |
Why?
|
| North America | 1 | 2015 | 314 | 0.030 |
Why?
|
| Vitamin K | 1 | 2014 | 54 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2018 | 739 | 0.030 |
Why?
|
| Vitamin A | 1 | 2014 | 94 | 0.030 |
Why?
|
| Vitamin E | 1 | 2014 | 136 | 0.030 |
Why?
|
| International Cooperation | 1 | 2015 | 323 | 0.030 |
Why?
|
| Vitamins | 1 | 2014 | 157 | 0.030 |
Why?
|
| Placebos | 1 | 2014 | 437 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 649 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 6550 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 1972 | 0.030 |
Why?
|
| Learning | 1 | 2017 | 403 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 644 | 0.030 |
Why?
|
| Social Behavior | 1 | 2015 | 306 | 0.030 |
Why?
|
| Reaction Time | 1 | 2013 | 234 | 0.030 |
Why?
|
| Vitamin D | 1 | 2014 | 261 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 1183 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 37905 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 658 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 5687 | 0.030 |
Why?
|
| Drainage | 1 | 2014 | 416 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 4320 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Emotions | 1 | 2015 | 562 | 0.020 |
Why?
|
| Algorithms | 1 | 2022 | 3890 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2014 | 558 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 2010 | 43 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 1544 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2010 | 88 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 2594 | 0.020 |
Why?
|
| Dehydration | 1 | 2010 | 87 | 0.020 |
Why?
|
| Compartment Syndromes | 1 | 2009 | 30 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2884 | 0.020 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2009 | 42 | 0.020 |
Why?
|
| Enoxaparin | 1 | 2009 | 66 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4744 | 0.020 |
Why?
|
| Diarrhea | 1 | 2011 | 686 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 844 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 4971 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2010 | 694 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 671 | 0.020 |
Why?
|
| Feces | 1 | 2010 | 770 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 6869 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 21445 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2009 | 384 | 0.020 |
Why?
|
| Decision Making | 1 | 2013 | 1287 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6100 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 12926 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 14889 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3639 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1360 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 9180 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 2483 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 3869 | 0.010 |
Why?
|
| United States | 1 | 2014 | 15433 | 0.010 |
Why?
|
| Middle Aged | 1 | 2022 | 86204 | 0.010 |
Why?
|